Latest Industry Insights
Industry Insight
Supporting Scientists Responding to the COVID-19 Pandemic
The development and implementation of efficient tests is crucial in efforts to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Industry Insight
An Automated Age for Western Blotting
Western blotting has been a core technique in molecular biology for many years, however, optimization and reproducibility can be problematic. We spoke to Dr Alexandre Lucas about the automation of western blotting and the difference this advance is making to research.
Industry Insight
How Can Artificial Intelligence Stop the Spread of Antimicrobial Resistance?
As we begin to see the light at the end of the COVID-19 pandemic, the threat of antimicrobial resistance has not gone away and remains a priority. Precision medicine company OpGen use molecular diagnostics and informatics to identify AMR before it can spread. To find out more, Technology Networks caught up with OpGen's CEO Oliver Schacht.
Industry Insight
Paving the Way for Personalized Medicine in Sepsis
In this interview, Dr Andreas Bergmann discusses how the quantification of two pathway-specific biomarkers can support the diagnosis, monitoring and treatment of sepsis patients.
Industry Insight
Detecting Mutations With Liquid Biopsies
Here we summarize the webinar that was hosted by Monika Seidel Ph.D., in which she discussed detecting mutations with liquid biopsies in cancer diagnostics.
Industry Insight
A “Losing” Proposition: Tackling the Problem of Lost or Unrecovered Analytes in Chromatography
Liquid chromatography has proven to be an invaluable tool in analytical labs. However, despite being a “mature” technique, there are still some areas that prove problematic, leading to suboptimal results. One such area is the loss of analytes during the chromatographic process, but design innovations are aiming to overcome this problem.
Industry Insight
Empowering Consumers With Point-of-Care Blood Testing
In this interview, Technology Networks spoke with Dr Dena Marrinucci, Truvian chief operating officer and co-founder, to learn more about the limitations of the current blood testing process and the role of point-of-care blood testing in driving healthier outcomes.
Industry Insight
New Test Enables Non-Invasive Detection of Endometrial Cancer
Arquer Diagnostics is developing non-invasive tests for diagnosing and monitoring cancer, using patented technology to detect the cancer biomarker MCM5. Technology Networks had the pleasure of speaking with Nadia Whittley, Chief Executive Officer of Arquer Diagnostics, to learn more about the study and its significance.
Industry Insight
Measuring the Antibody Response to SARS-CoV-2
To learn more about the ways that antibody tests are being used in the pandemic, Technology Networks spoke to Heather-Read Harper, European Senior Manager for Immunoassay and Clinical Chemistry at Beckman Coulter.
Industry Insight
PCR: The "Workhorse" Technology
Technology Networks spoke with Dr Jan Hellemans, CTO and co-founder of CRO Biogazelle, as well as co-author of the MIQE guidelines, to learn why PCR-based technologies are the "workhorse" technologies for the company.
Advertisement